This Solicitation opportunity from Michigan was posted on February 1, 2024. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Over the counter opioid reversal nasal spray
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
General Info
Place of Performance
MI, USASet-Aside
Documents
9AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Submission Closed
Organization & Contact Information
Full Description
The Michigan Department of Health and Human Services (MDHHS) has taken action to prevent prescription drug and opioid abuse deaths and increase access to treatment for people with an opioid use disorder. Refer to Exhibit E - List of Opioid Remediation Uses for a comprehensive list of core strategies to be administered. MDHHS has been purchasing Naloxone which is a life-saving medication used to reverse the side effects of an opioid overdose. In March 2023, the FDA approved the first OTC, nonprescription, naloxone hydrochloride nasal spray for nonprescription use.
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
